Karamanos Cancer Institute is a clinical research site located in Detroit, Michigan, United States 482018.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
Karamanos Cancer Institute has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer, Gastric Adenocarcinoma.
Sponsors: Roswell Park Cancer Institute, Gilead Sciences.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Michigan · View every site in Detroit
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Karamanos Cancer Institute has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Karamanos Cancer Institute has 2 clinical trials on record, with 1 currently active. Their work covers Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer, Gastric Adenocarcinoma.
Karamanos Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.